Literature DB >> 21502318

The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1,Ile4,Ile8]angiotensin II regulates a robust G protein-independent signaling network.

Ryan T Kendall1, Erik G Strungs, Saleh M Rachidi, Mi-Hye Lee, Hesham M El-Shewy, Deirdre K Luttrell, Michael G Janech, Louis M Luttrell.   

Abstract

The angiotensin II peptide analog [Sar(1),Ile(4),Ile(8)]AngII (SII) is a biased AT(1A) receptor agonist that stimulates receptor phosphorylation, β-arrestin recruitment, receptor internalization, and β-arrestin-dependent ERK1/2 activation without activating heterotrimeric G-proteins. To determine the scope of G-protein-independent AT(1A) receptor signaling, we performed a gel-based phosphoproteomic analysis of AngII and SII-induced signaling in HEK cells stably expressing AT(1A) receptors. A total of 34 differentially phosphorylated proteins were detected, of which 16 were unique to SII and eight to AngII stimulation. MALDI-TOF/TOF mass fingerprinting was employed to identify 24 SII-sensitive phosphoprotein spots, of which three (two peptide inhibitors of protein phosphatase 2A (I1PP2A and I2PP2A) and prostaglandin E synthase 3 (PGES3)) were selected for validation and further study. We found that phosphorylation of I2PP2A was associated with rapid and transient inhibition of a β-arrestin 2-associated pool of protein phosphatase 2A, leading to activation of Akt and increased phosphorylation of glycogen synthase kinase 3β in an arrestin signalsome complex. SII-stimulated PGES3 phosphorylation coincided with an increase in β-arrestin 1-associated PGES3 and an arrestin-dependent increase in cyclooxygenase 1-dependent prostaglandin E(2) synthesis. These findings suggest that AT(1A) receptors regulate a robust G protein-independent signaling network that affects protein phosphorylation and autocrine/paracrine prostaglandin production and that these pathways can be selectively modulated by biased ligands that antagonize G protein activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502318      PMCID: PMC3103364          DOI: 10.1074/jbc.M111.233080

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.

Authors:  Mi-Hye Lee; Hesham M El-Shewy; Deirdre K Luttrell; Louis M Luttrell
Journal:  J Biol Chem       Date:  2007-11-15       Impact factor: 5.157

Review 2.  Diversity in arrestin function.

Authors:  Ryan T Kendall; Louis M Luttrell
Journal:  Cell Mol Life Sci       Date:  2009-07-12       Impact factor: 9.261

3.  Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.

Authors:  L M Luttrell; F L Roudabush; E W Choy; W E Miller; M E Field; K L Pierce; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

4.  Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor.

Authors:  M S Ali; P P Sayeski; L B Dirksen; D J Hayzer; M B Marrero; K E Bernstein
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

5.  Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation.

Authors:  Thomas A Morinelli; Ryan T Kendall; Louis M Luttrell; Linda P Walker; Michael E Ullian
Journal:  J Pharmacol Exp Ther       Date:  2009-04-07       Impact factor: 4.030

6.  A signaling role of histone-binding proteins and INHAT subunits pp32 and Set/TAF-Ibeta in integrating chromatin hypoacetylation and transcriptional repression.

Authors:  Sara N Kutney; Rui Hong; Todd Macfarlan; Debabrata Chakravarti
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

7.  Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.

Authors:  Zhonghua Qi; Chuan-Ming Hao; Robert I Langenbach; Richard M Breyer; Reyadh Redha; Jason D Morrow; Matthew D Breyer
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

9.  Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes.

Authors:  J L Johnson; T G Beito; C J Krco; D O Toft
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Regulation of cytosolic prostaglandin E synthase by phosphorylation.

Authors:  Tsuyoshi Kobayashi; Yoshihito Nakatani; Toshihiro Tanioka; Masafumi Tsujimoto; Shigeo Nakajo; Kazuyasu Nakaya; Makoto Murakami; Ichiro Kudo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

View more
  33 in total

Review 1.  Regulation of β-adrenergic receptor function: an emphasis on receptor resensitization.

Authors:  Neelakantan T Vasudevan; Maradumane L Mohan; Shyamal K Goswami; Sathyamangla V Naga Prasad
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

2.  Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.

Authors:  Patrick T Reilly; Yun Yu; Ali Hamiche; Lishun Wang
Journal:  Bioessays       Date:  2014-08-25       Impact factor: 4.345

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  β-Arrestins 1 and 2 are critical regulators of inflammation.

Authors:  Hongkuan Fan
Journal:  Innate Immun       Date:  2013-09-12       Impact factor: 2.680

Review 5.  Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.

Authors:  Louis M Luttrell; Stuart Maudsley; Laura M Bohn
Journal:  Mol Pharmacol       Date:  2015-07-01       Impact factor: 4.436

Review 6.  Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks.

Authors:  Suleiman W Bahouth; Mohammed M Nooh
Journal:  Cell Signal       Date:  2017-04-24       Impact factor: 4.315

Review 7.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

8.  Delineation of a conserved arrestin-biased signaling repertoire in vivo.

Authors:  Stuart Maudsley; Bronwen Martin; Diane Gesty-Palmer; Huey Cheung; Calvin Johnson; Shamit Patel; Kevin G Becker; William H Wood; Yongqing Zhang; Elin Lehrmann; Louis M Luttrell
Journal:  Mol Pharmacol       Date:  2015-01-30       Impact factor: 4.436

Review 9.  Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

Authors:  Louis M Luttrell
Journal:  Mol Endocrinol       Date:  2014-01-16

10.  RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.

Authors:  Rukhsana Gul; Maya Ramdas; Chirag H Mandavia; James R Sowers; Lakshmi Pulakat
Journal:  Cardiorenal Med       Date:  2012-10-27       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.